Skip to main content

ADMA Biologics Inc. (ADMA)

NASDAQ: ADMA · IEX Real-Time Price · USD
1.45 -0.05 (-3.33%)
Nov 26, 2021 1:00 PM EST - Market closed
Market Cap283.93M
Revenue (ttm)68.52M
Net Income (ttm)-74.41M
Shares Out195.81M
EPS (ttm)-0.63
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,128,963
Open1.48
Previous Close1.50
Day's Range1.41 - 1.46
52-Week Range1.01 - 3.11
Beta1.25
AnalystsBuy
Price Target5.58 (+284.8%)
Earnings DateNov 10, 2021

About ADMA

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipel...

IndustryBiotechnology
Founded2004
Employees406
Stock ExchangeNASDAQ
Ticker SymbolADMA
Full Company Profile

Financial Performance

In 2020, ADMA Biologics's revenue was $42.22 million, an increase of 43.85% compared to the previous year's $29.35 million. Losses were -$75.75 million, 56.9% more than in 2019.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for ADMA Biologics stock is "Buy." The 12-month stock price forecast is 5.58, which is an increase of 284.83% from the latest price.

Price Target
$5.58
(284.83% upside)
Analyst Consensus: Buy

News

Are These Penny Stocks on Your Watchlist Right Now?

Check these penny stocks out for your watchlist The post Are These Penny Stocks on Your Watchlist Right Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:EDUSTRN
1 week ago - PennyStocks

ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of Directors

RAMSEY, N.J. and BOCA RATON, Fla., Nov. 17, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 week ago - GlobeNewsWire

ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC

ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional Facilities Under Construction ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional ...

1 week ago - GlobeNewsWire

ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double

ADMA Biologics Inc (NASDAQ: ADMA) achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million. The increase was favorably impacted by the continued commercial ramp-up of ADMA...

2 weeks ago - Benzinga

Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of 13.33% and 11.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

Generated Record Total Revenues of $20.7 Million in the Third Quarter 2021, a 101% Increase Over Third Quarter 2020

2 weeks ago - GlobeNewsWire

Preview: ADMA Biologics's Earnings

ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement.

2 weeks ago - Benzinga

ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021

Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET

3 weeks ago - GlobeNewsWire

Will Adma Biologics (ADMA) Report Negative Q3 Earnings? What You Should Know

Adma Biologics (ADMA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 weeks ago - Zacks Investment Research

ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters' Option to ...

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 25, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and dev...

1 month ago - GlobeNewsWire

Best Penny Stocks to Watch as The Market Turns Bullish

Penny stocks are seeing heightened momentum, which companies are you watching? The post Best Penny Stocks to Watch as The Market Turns Bullish appeared first on Penny Stocks to Buy, Picks, News and Info...

Other symbols:BRQSPBTS
1 month ago - PennyStocks

ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 22, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 month ago - GlobeNewsWire

ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 21, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 month ago - GlobeNewsWire

ADMA Biologics Announces Proposed Public Offering of Common Stock

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 20, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 month ago - GlobeNewsWire

ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory ...

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 month ago - GlobeNewsWire

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 18, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 month ago - GlobeNewsWire

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (...

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 month ago - GlobeNewsWire

ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufa...

1 month ago - GlobeNewsWire

ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, ...

2 months ago - GlobeNewsWire

ADMA Biologics' Aseptic Fill-Finish Machine Scores FDA Approval

The FDA has approved ADMA Biologics Inc's (NASDAQ:ADMA) in-house aseptic fill-finish machine, the VanRx SA25. Related Content:   ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Facility.

2 months ago - Benzinga

ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, ...

2 months ago - GlobeNewsWire

ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Facility

The FDA has approved ADMA Biologics Inc's (NASDAQ:ADMA) BioCenters plasma collection facility in Maryville, Tennessee.  The plasma collection facility commenced operations and initiated source plasma co...

3 months ago - Benzinga

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN

RAMSEY, N.J. and BOCA RATON, Fla. and MARYVILLE, Tenn., Aug. 16, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to ma...

3 months ago - GlobeNewsWire

Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of 0.00% and 7.73%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

Achieved Record Total Revenues of $17.8 Million in Second Quarter 2021, a 129% Increase Over Second Quarter 2020

3 months ago - GlobeNewsWire